Brief Summary: The goal of this RCT is to compare the Safety and efficacy of remimazolam compared with propofol under EEG DSA guiding during cardiac electrophysiology studies and ablation. The main questions it aims to answer are: * Is Remimazolam as efficacy as propofol in cardiac electrophysiology studies and ablation? * Is Remimazolam lower hypotension episodes or lower vasopressor dosages compare with propofol in cardiac electrophysiology studies and ablation? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\]. Researchers will compare Remimazolam to Propofol to see if Remimazolam is more feasible in cardiac electrophysiology studies and ablation. Participants will receive either Remimazolam or Propofol sedation during study period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
200
TIVA induction and maintain with Propofol.
TIVA induction and maintain with Remimazolam.
Patient receives intubation and controlled ventilation to maintain airway.
Patient maintains spontaneous ventilation without intubation.
Taipei Veterans General Hospital
Taipei, Taiwan
Hemodynamic stability--Vasopressor dosage
Total dosage of vasopressor used during the procedure
Time frame: Introperative
Respiratory depression require intubation
The incidence of patients in non-intubated groups receive intubation
Time frame: Introperative
TIVA failure rate
The incidence of TIVA shift to inhalation anesthetics
Time frame: Introperative
LOC time
Time from start induction to loss of conscious
Time frame: Introperative
Emergence time
Time from stop intravenous anesthetics infusion to eye opening
Time frame: Introperative
Sanctification of cardiologist
The sanctification score of the cardiologist
Time frame: Perioperative
QoR-15
The result of QoR-15 score
Time frame: Preoperative to post-operative day 1
Mini-Cog
The result of Mini-Cog score
Time frame: Preoperative to post-operative day 1
Length of hospital stay
Length of hospital stay
Time frame: Upto 1 month
Adverse outcome
Any adverse outcome
Time frame: Upto 1 month
Length of CU stay
Length of CU stay
Time frame: Upto 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.